Forest Laboratories | Evaluate

Scuttled IPOs cast pall on struggling biotech sector

US plays break-up artist as panic envelops Pfallergan

December 16, 2015

Astra bets on respiratory with Daliresp deal

November 24, 2015

Pfizer: The once and future M&A king

August 06, 2015

Upcoming events: Bayer takes chronic heart failure data and Trevena acute

July 15, 2015

M&A keeps up feverish pace in first half of 2015

May 28, 2015

IBS now an Actavis vs Valeant game

January 07, 2015

2014 another growth year as big cap stocks hold up

November 18, 2014

Allergan gets its happyish ending

October 03, 2014

Nine months into 2014, big drug stocks post strong performance

July 09, 2014

Huge second quarter for M&A sets 2014 on track for record year

Load More